Press Coverage

Chicago Drugmaker Recalls Neuromuscular Drug Due to Labeling Error

News brief about recall of cisatracurium due to some vials in lot being incorrectly labeled as phenylephrine mentions ISMP’s alert to practitioners as well as Food and Drug Administration (FDA) news release.

For the full text, visit Becker’s Hospital Review online.

More News

I knew if I wanted to become a subject matter expert and advance through the ranks of medication safety specialists, I needed to align myself with the organization considered the gold standard for medication safety information.